| Drug targeting to the brain AG De Boer, PJ Gaillard Annu. Rev. Pharmacol. Toxicol. 47, 323-355, 2007 | 452 | 2007 |
| Grey matter damage in multiple sclerosis: a pathology perspective R Klaver, HE De Vries, GJ Schenk, JJG Geurts Prion 7 (1), 66-75, 2013 | 130 | 2013 |
| What drives MRI-measured cortical atrophy in multiple sclerosis? V Popescu, R Klaver, P Voorn, Y Galis-de Graaf, DL Knol, JWR Twisk, ... Multiple Sclerosis Journal 21 (10), 1280-1290, 2015 | 122 | 2015 |
| Differential receptor-mediated drug targeting to the diseased brain J Rip, GJ Schenk, AG De Boer Expert opinion on drug delivery 6 (3), 227-237, 2009 | 119 | 2009 |
| Neuronal and axonal loss in normal-appearing gray matter and subpial lesions in multiple sclerosis R Klaver, V Popescu, P Voorn, Y Galis-de Graaf, P van der Valk, ... Journal of Neuropathology & Experimental Neurology 74 (5), 453-458, 2015 | 88 | 2015 |
| Unique spectral signatures of the nucleic acid dye acridine orange can distinguish cell death by apoptosis and necroptosis JR Plemel, AV Caprariello, MB Keough, TJ Henry, S Tsutsui, TH Chu, ... Journal of Cell Biology 216 (4), 1163-1181, 2017 | 67 | 2017 |
| Can subtle changes in gene expression be consistently detected with different microarray platforms? P Pedotti, PAC 't Hoen, E Vreugdenhil, GJ Schenk, RHAM Vossen, ... BMC genomics 9, 1-13, 2008 | 64 | 2008 |
| Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegeneration L van Olst, C Rodriguez-Mogeda, C Picon, S Kiljan, RE James, ... Acta Neuropathologica 141, 881-899, 2021 | 58 | 2021 |
| Axon‐myelin unit blistering as early event in MS normal appearing white matter A Luchicchi, B Hart, I Frigerio, AM van Dam, L Perna, HL Offerhaus, ... Annals of neurology 89 (4), 711-725, 2021 | 53 | 2021 |
| Transmigration of beta amyloid specific heavy chain antibody fragments across the in vitro blood–brain barrier KS Rutgers, RJA Nabuurs, SAA Van den Berg, GJ Schenk, M Rotman, ... Neuroscience 190, 37-42, 2011 | 51 | 2011 |
| Nile Red fluorescence spectroscopy reports early physicochemical changes in myelin with high sensitivity W Teo, AV Caprariello, ML Morgan, A Luchicchi, GJ Schenk, JT Joseph, ... Proceedings of the National Academy of Sciences 118 (8), e2016897118, 2021 | 48 | 2021 |
| Axonal degeneration as substrate of fractional anisotropy abnormalities in multiple sclerosis cortex P Preziosa, S Kiljan, MD Steenwijk, A Meani, WDJ van de Berg, ... Brain 142 (7), 1921-1937, 2019 | 46 | 2019 |
| Altered blood–brain barrier transport in neuro-inflammatory disorders GJ Schenk, HE de Vries Drug Discovery Today: Technologies 20, 5-11, 2016 | 43 | 2016 |
| Complement-associated loss of CA2 inhibitory synapses in the demyelinated hippocampus impairs memory V Ramaglia, M Dubey, MA Malpede, N Petersen, SI de Vries, SM Ahmed, ... Acta Neuropathologica 142 (4), 643-667, 2021 | 36 | 2021 |
| Oscillatory brain activity associates with neuroligin-3 expression and predicts progression free survival in patients with diffuse glioma J Derks, P Wesseling, EWS Carbo, A Hillebrand, E van Dellen, ... Journal of Neuro-oncology 140, 403-412, 2018 | 34 | 2018 |
| Insights into the mechanisms that may clarify obesity as a risk factor for multiple sclerosis MJD Huitema, GJ Schenk Current neurology and neuroscience reports 18, 1-9, 2018 | 33 | 2018 |
| Roles for HB‐EGF and CD9 in multiple sclerosis GJ Schenk, S Dijkstra, AJ van het Hof, SMA van der Pol, JAR Drexhage, ... Glia 61 (11), 1890-1905, 2013 | 33 | 2013 |
| A potential role for calcium / calmodulin‐dependent protein kinase‐related peptide in neuronal apoptosis: in vivo and in vitro evidence GJ Schenk, B Engels, YP Zhang, CP Fitzsimons, T Schouten, ... European Journal of Neuroscience 26 (12), 3411-3420, 2007 | 30 | 2007 |
| Endoplasmic reticulum stress in the dorsal root ganglia regulates large‐conductance potassium channels and contributes to pain in a model of multiple sclerosis MS Yousuf, S Samtleben, SM Lamothe, TN Friedman, A Catuneanu, ... The FASEB Journal 34 (9), 12577-12598, 2020 | 26 | 2020 |
| Versican promotes T helper 17 cytotoxic inflammation and impedes oligodendrocyte precursor cell remyelination S Ghorbani, E Jelinek, R Jain, B Buehner, C Li, BM Lozinski, S Sarkar, ... Nature communications 13 (1), 2445, 2022 | 24 | 2022 |
